Better Choice Company Appoints Renowned Expert in Rare and Undiagnosed Diseases, Dr. Paldeep S. Atwal, as its United States Special Healthcare Advisor

Rhea-AI Summary

Better Choice Company (NYSE: BTTR) has appointed Dr. Paldeep S. Atwal as its United States Special Healthcare Advisor. Dr. Atwal, a board-certified clinical and medical biochemical geneticist, brings extensive expertise in rare diseases and genomic medicine to the pet health and wellness company.

Dr. Atwal is the founder of Atwal Clinic for Genomic & Personalized Medicine in Palm Beach, FL, and previously served as Medical Director at both Everly Health Solutions and Mayo Clinic Florida's Individualized Medicine Clinic. The appointment comes as Better Choice approaches the completion of its SRx Health acquisition.

Chairman Michael Young emphasized that Dr. Atwal's expertise will be important for accelerating company growth, particularly in developing new offerings and strategic healthcare partnerships. Dr. Atwal's background includes notable achievements such as the ACMG Foundation/Genzyme Fellowship and training at prestigious institutions including Stanford University and Baylor College of Medicine.

Positive

• Strategic appointment of healthcare expert as company approaches SRx Health acquisition
• Addition of renowned medical expertise to support expansion into health and wellness offerings
• Potential for new strategic healthcare partnerships

Negative

• None.

TAMPA, Fla., March 04, 2025 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, today announced the appointment of Dr. Paldeep S. Atwal as its United States Special Healthcare Advisor.

Renowned for his expertise in rare and undiagnosed diseases, Dr. Atwal has dedicated his career to advancing the field of genomic medicine through cutting-edge diagnostics, research, and patient care. Dr. Atwal is a board-certified clinical and medical biochemical geneticist and the founder of Atwal Clinic for Genomic & Personalized Medicine, a premier private genetics clinic in Palm Beach, FL. Previously, he served as Medical Director of Genetic Services at Everly Health Solutions (formerly PWNHealth), a leading virtual healthcare company, and as Medical Director for the Individualized Medicine Clinic at Mayo Clinic in Florida, where he played a pivotal role in advancing precision medicine initiatives.

"As we near the closing of our acquisition of SRx Health, it is critical we continue to build our team with healthcare professionals and experts such as Dr. Atwal," said Michael Young, Chairman of Better Choice. "Dr. Atwal’s appointment will be key in accelerating the our growth, particularly in new offerings, strategic healthcare partnerships, and aligning with the evolving wellness and preventative health landscape. Dr. Atwal's pioneering work in genomic medicine, combined with his vast expertise in rare diseases and personalized care, will be invaluable as we continue to innovate and expand our health and wellness offerings. His strategic vision will be instrumental in shaping our future initiatives and ensuring we lead the way in delivering impactful health solutions that truly improve lives."

As a recognized leader in genomic medicine, Dr. Atwal is committed to advancing personalized, science-driven care, with his pioneering contributions earning numerous prestigious awards, including the ACMG Foundation/Genzyme Fellowship, and the Neurobiology of Disease in Children Young Investigator Award. Dr. Atwal earned his medical degree from the University of Glasgow and trained in internal medicine at Glasgow Royal Infirmary with the Royal College of Physicians. He also pursued a genetics fellowship at Stanford University and a sub-specialty biochemical genetics fellowship at Baylor College of Medicine, where he contributed to the development of a clinical metabolomic profiling test.

About Better Choice Company Inc.
Better Choice Company Inc. is a rapidly growing pet health and wellness company committed to leading the industry shift toward pet products and services that help dogs and cats live healthier, happier, and longer lives. We take an alternative, nutrition-based approach to pet health relative to conventional dog and cat food offerings and position our portfolio of brands to benefit from the mainstream trends of growing pet humanization and consumer focus on health and wellness. We have a demonstrated, multi-decade track record of success selling trusted pet health and wellness products and leverage our established digital footprint to provide pet parents with the knowledge to make informed decisions about their pet’s health. We sell the majority of our dog food, cat food and treats under the Halo brand, which is focused, respectively, on providing sustainably sourced kibble and canned food derived from real whole meat, and minimally processed raw-diet dog food and treats. For more information, please visit https://www.betterchoicecompany.com.

Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. The Company has based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Some or all of the results anticipated by these forward-looking statements may not be achieved. Further information on the Company’s risk factors is contained in our filings with the SEC. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.

Company Contact:
Better Choice Company, Inc.
Kent Cunningham, CEO

Investor Contact:
KCSA Strategic Communications
Valter Pinto, Managing Director
T: 212-896-1254
Valter@KCSA.com

FAQ

What is the significance of Dr. Atwal's appointment for Better Choice Company (BTTR)?

Dr. Atwal's appointment will help accelerate growth in new offerings and strategic healthcare partnerships, particularly as BTTR nears completion of the SRx Health acquisition.

What are Dr. Atwal's key credentials and experience before joining BTTR?

He is a board-certified geneticist, founder of Atwal Clinic, former Medical Director at Everly Health Solutions and Mayo Clinic Florida, with training from Stanford University and Baylor College of Medicine.

How does Dr. Atwal's expertise align with Better Choice's future strategy?

His expertise in genomic medicine and personalized care will help BTTR innovate and expand their health and wellness offerings, focusing on preventative health solutions.

What major acquisition is Better Choice (BTTR) currently finalizing?

BTTR is nearing the closing of its acquisition of SRx Health.